- Home
- GOVX vs SHFS Comparison
GOVX vs SHFS Comparison
Compare GOVX & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- SHFS
- Stock Information
- Founded
- GOVX 2001
- SHFS 2015
- Country
- GOVX United States
- SHFS United States
- Employees
- GOVX N/A
- SHFS N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- SHFS Finance: Consumer Services
- Sector
- GOVX Health Care
- SHFS Finance
- Exchange
- GOVX Nasdaq
- SHFS Nasdaq
- Market Cap
- GOVX 23.8M
- SHFS 24.2M
- IPO Year
- GOVX N/A
- SHFS N/A
- Fundamental
- Price
- GOVX $2.22
- SHFS $0.39
- Analyst Decision
- GOVX Strong Buy
- SHFS
- Analyst Count
- GOVX 5
- SHFS 0
- Target Price
- GOVX $14.20
- SHFS N/A
- AVG Volume (30 Days)
- GOVX 759.4K
- SHFS 336.3K
- Earning Date
- GOVX 02-27-2025
- SHFS 11-12-2024
- Dividend Yield
- GOVX N/A
- SHFS N/A
- EPS Growth
- GOVX N/A
- SHFS N/A
- EPS
- GOVX N/A
- SHFS 0.10
- Revenue
- GOVX $3,090,161.00
- SHFS $15,658,629.00
- Revenue This Year
- GOVX N/A
- SHFS N/A
- Revenue Next Year
- GOVX $150.51
- SHFS N/A
- P/E Ratio
- GOVX N/A
- SHFS $3.81
- Revenue Growth
- GOVX N/A
- SHFS 7.78
- 52 Week Low
- GOVX $1.09
- SHFS $0.30
- 52 Week High
- GOVX $11.18
- SHFS $1.39
- Technical
- Relative Strength Index (RSI)
- GOVX 44.57
- SHFS 46.88
- Support Level
- GOVX $2.04
- SHFS $0.32
- Resistance Level
- GOVX $2.32
- SHFS $0.42
- Average True Range (ATR)
- GOVX 0.18
- SHFS 0.04
- MACD
- GOVX -0.02
- SHFS -0.00
- Stochastic Oscillator
- GOVX 25.35
- SHFS 44.30
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.